Oriola Corp (OHEL:ORIOLA)
€ 0.93 +0.0050 (+0.54%) Market Cap: 170.61 Mil Enterprise Value: 112.21 Mil PE Ratio: 0 PB Ratio: 1.85 GF Score: 62/100

Q4 2024 Oriola Oyj Earnings Call Transcript

Mar 04, 2025 / 08:00AM GMT
Release Date Price: €1 (-2.53%)

Key Points

Positve
  • Oriola Corp (OHEL:OKDAV) reported a 3% organic growth in net sales, reaching EUR1.7 billion.
  • The adjusted EBIT increased by 30%, from EUR16.7 million to EUR21.7 million.
  • The company has strengthened customer centricity, working closely with both upstream and downstream customers.
  • The wholesale segment showed a 5% growth, supported by a wider offering and new sales channels.
  • Oriola Corp (OHEL:OKDAV) introduced data-driven services, utilizing AI to enhance advisory services for pharmaceutical companies.
Negative
  • Kronans Apotek's performance was unsatisfactory, with expectations to reach market standards only by 2027.
  • The operating environment remains challenging with weak consumer confidence in Finland and Sweden.
  • Cost inflation, although slowing, continues to impact visibility on energy and fuel prices.
  • The company faced higher operational expenses in December due to increased volumes during the holiday season.
  • The ERP project costs are significant, with EUR5.9 million booked as adjusting items, impacting net results.
Tua Stenius;Ornhjelm;Katarina
Oriola Oyj - Investor Relations and Sustainability Manager

Good morning everyone, and a warm welcome to Oriola Q4 and full year results webcast. My name is Tua Stenius-Ornhjelm and I am from Oriola Investor Relations. With me today I have our CEO; Katarina Gabrielson and CFO Mats Danielsson.

After the presentation, we will open up for your questions, but I would like to remind you that we will focus on the questions relating to Oriola's business and financial performance and take questions about Kronans Apotekâs only within the limited scope that we can comment on.

You can send in your questions already during the presentation using the chat function in the webcast player. I would also like to remind you that we are recording this webcast, and the on-demand version will be available on our website at a later point today. And now if we go to the next slide here we have the customary disclaimer that we all should be aware of and now without further ado.

I would like to hand over to Katarina, please go ahead.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot